Drug · DIN 02264803
RATIO-RISPERIDONE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 26, 2015; first marketed July 5, 2006.
- Drug Identification Number (DIN)
- 02264803
- Company (DIN owner)
- Ratiopharm Inc Division Of Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 3.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 5, 2006: NOC 8118Abbreviated New Drug Submission (ANDS)
Other DINs named RATIO-RISPERIDONE
- DIN 02264757 · Cancelled Post Market
- DIN 02264765 · Cancelled Post Market
- DIN 02264773 · Cancelled Post Market
- DIN 02264781 · Cancelled Post Market
- DIN 02264811 · Cancelled Post Market